Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to $1.1 million.

  • Rockwell Medical's Net Cash Flow rose 12647.06% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 7330.86%. This contributed to the annual value of $6.7 million for FY2024, which is 69946.19% up from last year.
  • Latest data reveals that Rockwell Medical reported Net Cash Flow of $1.1 million as of Q3 2025, which was up 12647.06% from $1.1 million recorded in Q2 2025.
  • Rockwell Medical's Net Cash Flow's 5-year high stood at $20.9 million during Q2 2022, with a 5-year trough of -$17.8 million in Q3 2022.
  • In the last 5 years, Rockwell Medical's Net Cash Flow had a median value of -$1.9 million in 2023 and averaged -$1.8 million.
  • As far as peak fluctuations go, Rockwell Medical's Net Cash Flow soared by 73293.9% in 2022, and later plummeted by 39446.54% in 2024.
  • Quarter analysis of 5 years shows Rockwell Medical's Net Cash Flow stood at -$10.1 million in 2021, then skyrocketed by 71.53% to -$2.9 million in 2022, then skyrocketed by 142.49% to $1.2 million in 2023, then soared by 171.87% to $3.3 million in 2024, then plummeted by 67.58% to $1.1 million in 2025.
  • Its last three reported values are $1.1 million in Q3 2025, $1.1 million for Q2 2025, and -$4.3 million during Q1 2025.